HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
340B
Subscribe to 340B's Posts

This Week in 340B: November 19 – December 2, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: HRSA Audit Process; Contract Pharmacy; Other

  • In four Health Resources and Services Administration (HRSA) audit process cases, the plaintiffs filed motions for a temporary restraining order.
  • In four HRSA audit process cases, the courts approved a joint motion to withdraw the plaintiff’s previously-flied motion for a temporary restraining order.
  • In a Freedom of Information Act (FOIA) case, the drug manufacturer plaintiff filed a reply in support of its motion for summary judgment and opposition to defendants’ motion for partial summary judgment.
  • A drug manufacturer filed suit against HRSA to challenge HRSA’s disapproval of its proposed rebate model.
  • In eight cases challenging proposed state laws governing contract pharmacy arrangements in West Virginia and Missouri:
    • WV: The court in four separate cases granted the parties’ joint motions and stipulations to delay proceedings for fourteen days to allow related courts to decide pending preliminary injunction motions in similar cases.
    • MO: In two cases, the plaintiff filed suggestion in opposition to intervenor’s motion to [...]

      Continue Reading



read more

California Ballot Proposition 34 Targets Spending by Certain 340B Covered Entities

Proposition 34 requires certain California healthcare providers to spend at least 98% of their net drug sale revenue on direct patient care. The measure targets certain providers who benefit from a federal drug discount program known as the 340B Program.

The 340B Program allows qualifying safety net healthcare providers who serve a disproportionate share of low-income and uninsured patients to purchase outpatient drugs at a significant discount. The intent of the 340B Program is to allow providers that participate in the program to offer more comprehensive services to patients and their communities.

The 340B Program does not dictate how eligible providers use revenue generated from sales of the discounted drugs. Proposition 34 imposes such restrictions.

Who Does It Affect?

Not all providers who participate in the 340B Program are affected by Proposition 34. It only applies to 340B providers that:

  • Spend more than $100 million on non-direct-care expenses.
  • Own and operate apartment buildings.
  • Have accumulated at least 500 severe health and safety violations in the past decade.

Currently, the AIDS Healthcare Foundation (AHF) is believed to be the only organization that meets these criteria.

Background and Controversy

Proposition 34 is one of the first state-level efforts to restrict use of savings generated from participation in the 340B Program. Opponents of Proposition 34 believe that it was on the ballot largely due to political and housing interest groups’ opposition to the president of AHF and certain spending by AHF under his leadership. AHF has become a significant player in [...]

Continue Reading




read more

This Week in 340B: November 12 – 18, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: ADR Rule; Contract Pharmacy; HRSA; Other

  • In a case challenging the Health Resources and Services Administration (HRSA’s) policy prohibiting all manufacturer conditions on 340B transactions, the plaintiff filed a first amended complaint for declaratory and injunctive relief.
  • In a case concerning the Alternative Dispute Resolution (ADR) rule, the parties filed a stipulation of dismissal.
  • In a contract pharmacy case, the defendants filed a cross motion for partial summary judgment and a motion in opposition to the plaintiff’s motion for summary judgment, and responded to a drug manufacturer’s motion for leave to file an amicus brief.
  • Two drug manufacturers each filed a complaint against HRSA to challenge HRSA’s decision not to allow their proposed rebate models.
  • In four cases challenging proposed state laws governing contract pharmacy arrangements in Missouri and Mississippi:
    1. MO: In two cases, the court granted proposed intervenors’ motion to intervene and intervenors subsequently filed a motion for dismiss.
    2. MS: In two cases, two separate groups of amici filed amicus briefs in [...]

      Continue Reading



read more

This Week in 340B: November 5 – 11, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy

  1. In nine cases challenging proposed state laws governing contract pharmacy arrangements in West Virginia, Missouri, Kansas, and the Fifth Circuit Court of Appeals:
    1. MO: In one case, the proposed intervenors filed a motion to dismiss. In a second case, plaintiff filed suggestions in support of proposed intervenor’s motion to intervene.
    2. KS: Amici filed a motion to file an amicus brief.
    3. WV: Defendants in four separate cases filed identical motions to consolidate cases, along with supporting memoranda.
    4. Fifth Circuit: Defendants in two separate cases filed reply briefs.



read more

This Week in 340B: October 29 – November 4, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; HRSA; Other

– A healthcare improvement company filed suit against HRSA to challenge HRSA’s policy limiting the circumstances in which covered entities can use their group purchasing arrangements to purchase non-340B drugs.

– A covered entity filed suit against an insurance company alleging that the insurance company failed to reimburse the covered entity for amounts it paid the covered entity using the unlawful Medicare rate of ASP minus 22.5%.

– In a contract pharmacy case, a drug manufacturer filed a motion for leave to file an amicus curiae brief in support of plaintiff’s motion for summary judgment.

– In eleven cases challenging proposed state laws governing contract pharmacy arrangements in Mississippi, West Virginia, Missouri, and Kansas:

  • MS: The plaintiff filed a rebuttal in support of its motion for preliminary injunction.
  • WV:

– In two cases, the parties filed joint motions for stays of deadlines.

– In two other cases, plaintiffs filed responses to defendants’ notices of supplemental [...]

Continue Reading




read more

This Week in 340B: October 22 – 28, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: HRSA; Contract Pharmacy; Other

  • In an appealed qui tam action alleging that various drug manufacturers failed to charge accurate ceiling prices to 340B Covered Entities, an amicus brief was filed in support of the appellees.
  • In a case challenging HRSA’s policy prohibiting all manufacturer conditions on 340B transactions, the parties filed a joint status report.
  • In two cases challenging proposed Missouri state law governing contract pharmacy arrangements, the defendants filed a motion to dismiss and a memorandum in support thereof in one case and the defendants filed a reply in support of the defendant’s motion to dismiss in a second case. In addition, plaintiffs in the second case filed a memorandum in opposition to proposed intervenors’ motion to intervene.



read more

This Week in 340B: October 15 – 21, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In an appealed qui tam action alleging that various drug manufacturers failed to charge accurate ceiling prices to 340B Covered Entities, the appellees filed an answering brief.
  • In nine cases challenging proposed state laws governing contract pharmacy arrangements in Mississippi, Louisiana, Minnesota, West Virginia and Missouri:
    • LA: The plaintiff filed an appeal.
    • MN: The defendant in two related cases filed a reply in support of their motion to dismiss.
    • WV: The defendant in three cases filed notices of supplemental authority
    • MO:
      • In one case, three amici filed a motion for leave to file an amicus brief with the court, defendants filed a memorandum in support of their motion to dismiss, two intervenors filed a verified motion to intervene and suggestions in support, and plaintiffs filed a response to defendant’s motion to dismiss.
      • In another case, plaintiffs filed a response to defendant’s motion to transfer.
    • MS: The defendant filed a reply in opposition to the plaintiff’s motion for [...]

      Continue Reading



read more

This Week in 340B: October 8 – 14, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy

  • In eight cases challenging proposed state law governing contract pharmacy arrangements, in Louisiana, Missouri, Minnesota, and Kansas:
    • LA: the Plaintiff filed an appeal.
    • MO: amici filed a motion for leave to file an amicus brief in one case and Defendants filed a reply in support of its motion to transfer venue.
    • KS: the court filed an order to consolidate all contract pharmacy cases for discovery purposes only.
    • MN: the Plaintiffs in each of two cases filed an opposition to Defendant’s motion to dismiss.



read more

This Week in 340B: October 1 – 7, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker, a subscription product from McDermott+.

Issues at Stake: Contract Pharmacy; Other

  • In an appealed action alleging that various drug manufacturers failed to charge accurate ceiling prices to 340B Covered Entities, the 340B Covered Entity plaintiff filed its reply brief.
  • In seven cases challenging a proposed state law governing contract pharmacy arrangements:
    • LA: The plaintiff filed an appeal to the Fifth Circuit.
    • MO: The defendants filed a motion to transfer in one case and a motion to dismiss in a separate case. In a third case, amici filed a brief in support of defendants’ motion to dismiss and opposition to plaintiff’s motion for preliminary injunction.
    • AR: The court denied the intervenor’s motion to dismiss.
    • MN: In two cases, a group of amici filed an amici curiae brief in support of the defendant’s motion to dismiss.



read more

This Week in 340B: September 24 – 30, 2024

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker, a subscription product from McDermott+.

Issues at Stake: HRSA; Contract Pharmacy

  • In a case challenging HRSA’s policy prohibiting all manufacturer conditions on 340B transactions, the parties filed a joint status report.
  • In six cases challenging proposed state laws governing contract pharmacy arrangements in Louisiana, Missouri, and Maryland:
    • LA: The court ruled on motions for summary judgement.
    • MO: Proposed intervenors filed a motion to intervene and a motion to dismiss with suggestions in support of each motion. In a second case, plaintiff filed suggestions in opposition to reassign or transfer the case to a different forum.
    • MD: The plaintiffs filed a reply in support of their motion for expedited discovery, and a notice of appeal of the court’s decision to deny their motion for preliminary injunction.



read more

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm